Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL
ClinicalTrials.gov study NCT02656147. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
ClinicalTrials.gov study NCT03886649. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas
ClinicalTrials.gov study NCT02055924. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP
ClinicalTrials.gov study NCT05798156. IPD Sharing: NO. Countries: 2. Publications: 0.
KSV01 Injection for the Treatment of Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07260812. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects
ClinicalTrials.gov study NCT06074107. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-Synthetic T Cell Antigen Receptor(STAR)-T in B-cell Malignancies Patients
ClinicalTrials.gov study NCT03953599. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial
ClinicalTrials.gov study NCT07165769. IPD Sharing: NO. Countries: 1. Publications: 0.
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
ClinicalTrials.gov study NCT06588205. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00450944. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease
ClinicalTrials.gov study NCT00209014. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Navitoclax in Addition to Bendamustine and Rituximab in Patients With Relapsed Diffuse Large B-Cell Lymphoma (NAVIGATE)
ClinicalTrials.gov study NCT01423539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05667155. IPD Sharing: NO. Countries: 1. Publications: 0.
An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under
ClinicalTrials.gov study NCT06782789. IPD Sharing: NO. Countries: 1. Publications: 0.
A Sub-study Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) in China
ClinicalTrials.gov study NCT07226752. IPD Sharing: NO. Countries: 1. Publications: 0.
Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblas
ClinicalTrials.gov study NCT07105579. IPD Sharing: NO. Countries: 1. Publications: 0.
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01410630. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT04696692. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00689845. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients
ClinicalTrials.gov study NCT00846157. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.